作者
Benjamin Ruf,Matthias Bruhns,Sepideh Babaei,Noémi Kedei,Lichun Ma,Mahler Revsine,Mohamed-Reda Benmebarek,Chi Ma,Bernd Heinrich,Varun Subramanyam,Jonathan Qi,Simon Wabitsch,Benjamin L. Green,Kylynda C. Bauer,Yuta Myojin,Layla T. Greten,Justin McCallen,Patrick Huang,Rajiv Trehan,Xin Wei Wang,Amran Nur,Dana Q. M. Soika,Marie Pouzolles,Christine N. Evans,Raj Chari,David E. Kleiner,William G. Telford,Kimia Dadkhah,Allison Ruchinskas,Merrill K. Stovroff,Ji‐Man Kang,Kesha Oza,Mathuros Ruchirawat,Alexander Kroemer,Xin Wei Wang,Manfred Claassen,Firouzeh Korangy,Tim F. Greten
摘要
Summary
Mucosal-associated invariant T (MAIT) cells represent an abundant innate-like T cell subtype in the human liver. MAIT cells are assigned crucial roles in regulating immunity and inflammation, yet their role in liver cancer remains elusive. Here, we present a MAIT cell-centered profiling of hepatocellular carcinoma (HCC) using scRNA-seq, flow cytometry, and co-detection by indexing (CODEX) imaging of paired patient samples. These analyses highlight the heterogeneity and dysfunctionality of MAIT cells in HCC and their defective capacity to infiltrate liver tumors. Machine-learning tools were used to dissect the spatial cellular interaction network within the MAIT cell neighborhood. Co-localization in the adjacent liver and interaction between niche-occupying CSF1R+PD-L1+ tumor-associated macrophages (TAMs) and MAIT cells was identified as a key regulatory element of MAIT cell dysfunction. Perturbation of this cell-cell interaction in ex vivo co-culture studies using patient samples and murine models reinvigorated MAIT cell cytotoxicity. These studies suggest that aPD-1/aPD-L1 therapies target MAIT cells in HCC patients.